Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
4.100
+0.030 (0.74%)
At close: Sep 17, 2026, 4:00 PM EDT
4.052
-0.048 (-1.18%)
After-hours: Sep 17, 2026, 8:00 PM EDT
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $152.45 million as of September 17, 2026. Its market cap has increased by 46.10% in one year.
Market Cap
152.45M
Enterprise Value
442.45M
1-Year Change
46.10%
Ranking
Category
Stock Price
$4.10
ChartMarket Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $152.45M, an increase of 229.16%. That is a compound annual growth rate of 17.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 152.45M | -33.32% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MediWound | 173.90M |
| Atrium Therapeutics | 172.60M |
| Innate Pharma | 167.85M |
| Outlook Therapeutics | 163.84M |
| Canton Strategic Holdings | 162.95M |
| Spruce Biosciences | 158.54M |
| Molecular Partners AG | 157.60M |
| Jyong Biotech | 157.37M |